VREOD (Vireo Growth) Moat Score: 2/10 (As of Jun. 26, 2026)


VREOD Vireo Growth Inc VREOD
52 GF Score
Price $9.99
GF Value $9.09
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Vireo Growth Moat Score?

Vireo Growth VREOD -0.15% 52 Moat Score is 2 as of Jun. 26, 2026. GuruFocus rates VREOD with a GF Score™ of 52/100 and a GF Value™ of $9.09 (Fairly Valued). The stock has 6 warning signs investors should review. Among 1,033 Drug Manufacturers companies, Vireo Growth ranks better than 81.7% on this metric.

Vireo Growth has the Moat Score of 2, which implies that the company might have No Moat - Very weak/transient advantages.

Vireo Growth has No Moat: Vireo Growth operates in a competitive market with minimal differentiation. The company lacks significant intellectual property, brand strength, or regulatory barriers. Its cost structure and distribution network do not provide a sustainable advantage, and there is no evidence of strong customer loyalty or switching costs.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Vireo Growth might have No Moat - Very weak/transient advantages.

Vireo Growth  (OTCPK:VREOD) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Vireo Growth Moat Score Related Terms

VREOD vs ZTS: Moat Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Vireo Growth's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vireo Growth Moat Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vireo Growth's Moat Score distribution charts can be found below:

* The bar in red indicates where Vireo Growth's Moat Score falls into.


VREOD
52GF Score
Vireo Growth Inc VREOD
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 2 mean?
Vireo Growth (VREOD) has a Moat Score of 2 as of Jun. 26, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Vireo Growth ranks #189 out of 1033 companies in the Drug Manufacturers industry, placing it in the top 18.3%.
Is Vireo Growth's Moat Score too high?
Vireo Growth's current Moat Score is 2. Based on the distribution chart, Vireo Growth ranks #189 out of 1033 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Vireo Growth has a GF Score™ of 52/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Vireo Growth's Moat Score compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Vireo Growth ranks #189 out of 1033 companies for Moat Score. This places Vireo Growth in the top 18% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Drug Manufacturers company?
A good Moat Score depends on the Drug Manufacturers industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Vireo Growth's current Moat Score is 2. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vireo Growth stock overvalued right now?
Based on GuruFocus' analysis, Vireo Growth (VREOD) is currently considered Fairly Valued. The stock's GF Value™ is $9.09, compared to a current price of $9.99 — trading 9.8% above its estimated fair value. The current Moat Score is 2. Vireo Growth's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Vireo Growth (VREOD), the current Moat Score is 2 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vireo Growth (VREOD) Overvalued in 2026?

Based on GuruFocus' analysis, Vireo Growth stock appears to be overvalued. The current stock price of $9.99 is trading 9.8% above its estimated GF Value™ of $9.09. GuruFocus considers Vireo Growth to be Fairly Valued.

Key valuation signals for VREOD:

  • Moat Score: 2
  • GF Value™: $9.09 vs. price of $9.99 (9.8% above fair value)
  • GF Score™: 52/100 with 6 warning signs

No single metric tells the full story. See the VREOD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vireo Growth Business Description

Other Exchanges K95:GermanyVREO:Canada
Address 207 South 9th Street, Minneapolis, Minneapolis, MN, USA, 55402
Vireo Growth Incis a cannabis company whose mission is to provide safe access, quality products and value to its customers while supporting its local communities through active participation and restorative justice programs. The Company is evolving with the industry and is in the midst of a transformation to being significantly more customer-centric across its operations, which include cultivation, manufacturing, wholesale and retail business lines. The company operates in one single segment.
52GF Score

Get the complete analysis for VREOD

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.99
Price
$9.09
GF Value